$FULC
Fulcrum Therapeutics, Inc.

2022 Q3 Form 10-Q Financial Statement

#000095017022016644 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $1.183M $1.882M $2.592M
YoY Change -76.03% -57.04% -45.88%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.707M $11.10M $10.76M
YoY Change 12.51% 66.01% 95.62%
% of Gross Profit
Research & Development $15.37M $25.02M $17.83M
YoY Change -10.02% 43.97% 9.16%
% of Gross Profit
Depreciation & Amortization $600.0K $700.0K $500.0K
YoY Change 0.0% 0.0% -16.67%
% of Gross Profit
Operating Expenses $25.54M $36.12M $28.59M
YoY Change -0.65% 50.09% 30.95%
Operating Profit -$24.36M -$34.24M -$26.00M
YoY Change 17.26% 73.94% 52.54%
Interest Expense $617.0K $165.0K $70.00K
YoY Change 1042.59% 385.29% 59.09%
% of Operating Profit
Other Income/Expense, Net $617.0K $165.0K $70.00K
YoY Change 1042.59% 385.29% 75.0%
Pretax Income -$23.74M -$34.07M -$25.93M
YoY Change 14.59% 73.4% 52.52%
Income Tax
% Of Pretax Income
Net Earnings -$23.74M -$34.07M -$25.93M
YoY Change 14.59% 73.4% 52.53%
Net Earnings / Revenue -2006.59% -1810.31% -1000.31%
Basic Earnings Per Share -$0.51 -$0.83 -$0.64
Diluted Earnings Per Share -$0.51 -$0.83 -$637.9K
COMMON SHARES
Basic Shares Outstanding 41.01M 40.89K 40.64M
Diluted Shares Outstanding 46.21K 40.89K 40.64K

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $221.8M $169.0M $195.1M
YoY Change -7.72% 34.59% 35.59%
Cash & Equivalents $90.94M $40.15M $33.31M
Short-Term Investments $130.9M $128.8M $161.8M
Other Short-Term Assets $4.701M $3.782M $47.00K
YoY Change 12271.05% 34281.82% -81.78%
Inventory
Prepaid Expenses
Receivables $1.237M $1.492M $1.208M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $227.7M $174.2M $200.1M
YoY Change -7.5% 35.59% 36.1%
LONG-TERM ASSETS
Property, Plant & Equipment $7.375M $7.834M $7.888M
YoY Change -4.83% 1.15% 1.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.098M $2.106M $816.0K
YoY Change 304.24% 29.76% -52.0%
Total Long-Term Assets $20.08M $20.99M $20.18M
YoY Change 114.51% 124.02% 112.46%
TOTAL ASSETS
Total Short-Term Assets $227.7M $174.2M $200.1M
Total Long-Term Assets $20.08M $20.99M $20.18M
Total Assets $247.8M $195.2M $220.2M
YoY Change -3.03% 41.6% 40.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.728M $5.385M $6.003M
YoY Change -27.1% 19.72% 25.06%
Accrued Expenses $10.56M $14.94M $9.231M
YoY Change 3.52% 96.59% 77.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.70M $22.12M $18.29M
YoY Change -28.64% -1.73% -19.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $197.0K $197.0K $12.80M
YoY Change -95.46% -95.6% 109.84%
Total Long-Term Liabilities $197.0K $197.0K $12.80M
YoY Change -95.46% -95.6% 109.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.70M $22.12M $18.29M
Total Long-Term Liabilities $197.0K $197.0K $12.80M
Total Liabilities $26.39M $34.48M $31.09M
YoY Change 5.83% 27.75% 8.32%
SHAREHOLDERS EQUITY
Retained Earnings -$386.2M -$362.5M -$328.4M
YoY Change 38.42% 40.34%
Common Stock $608.5M $524.3M $518.6M
YoY Change 19.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $0.00 $0.00
YoY Change
Treasury Stock Shares $0.00 $0.00 $0.00
Shareholders Equity $221.4M $160.8M $189.2M
YoY Change
Total Liabilities & Shareholders Equity $247.8M $195.2M $220.2M
YoY Change -3.03% 41.6% 40.73%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$23.74M -$34.07M -$25.93M
YoY Change 14.59% 73.4% 52.53%
Depreciation, Depletion And Amortization $600.0K $700.0K $500.0K
YoY Change 0.0% 0.0% -16.67%
Cash From Operating Activities -$27.88M -$27.37M -$22.11M
YoY Change 23.52% 53.59% 36.24%
INVESTING ACTIVITIES
Capital Expenditures -$283.0K -$1.318M $246.0K
YoY Change -22.89% 132.45% -6.11%
Acquisitions
YoY Change
Other Investing Activities -$1.996M $32.71M $19.91M
YoY Change -98.12% -226.83% 56.98%
Cash From Investing Activities -$2.279M $31.40M $19.66M
YoY Change -97.86% -219.11% 58.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $348.0K
YoY Change 274.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.95M 2.811M 348.0K
YoY Change -41.3% 1219.72% -99.27%
NET CHANGE
Cash From Operating Activities -27.88M -27.37M -22.11M
Cash From Investing Activities -2.279M 31.40M 19.66M
Cash From Financing Activities 80.95M 2.811M 348.0K
Net Change In Cash 50.79M 6.840M -2.099M
YoY Change 484.14% -115.56% -104.8%
FREE CASH FLOW
Cash From Operating Activities -$27.88M -$27.37M -$22.11M
Capital Expenditures -$283.0K -$1.318M $246.0K
Free Cash Flow -$27.60M -$26.05M -$22.35M
YoY Change 24.29% 51.0% 35.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation
ShareBasedCompensation
6726000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40153000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35412000
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001680581
CY2022Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity File Number
EntityFileNumber
001-38978
dei Entity Registrant Name
EntityRegistrantName
FULCRUM THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4839948
dei Entity Address Address Line1
EntityAddressAddressLine1
26 Landsdowne Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02139
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
651-8851
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
FULC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41009442
CY2022Q2 us-gaap Marketable Securities
MarketableSecurities
128820000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
182750000
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
357000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2500000
CY2022Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
743000
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1137000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4174000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4199000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
174247000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
225998000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7834000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7368000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9954000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1092000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1092000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2106000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
542000
CY2022Q2 us-gaap Assets
Assets
195233000
CY2021Q4 us-gaap Assets
Assets
235000000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5385000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4788000
CY2022Q2 fulc Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
12470000
CY2021Q4 fulc Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
9231000
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1782000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4711000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2484000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q2 us-gaap Lease Incentive Payable Current
LeaseIncentivePayableCurrent
0
CY2021Q4 us-gaap Lease Incentive Payable Current
LeaseIncentivePayableCurrent
469000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22121000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19199000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12160000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
197000
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1680000
CY2022Q2 fulc Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
0
CY2021Q4 fulc Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
2582000
CY2022Q2 us-gaap Liabilities
Liabilities
34478000
CY2021Q4 us-gaap Liabilities
Liabilities
23461000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41008205
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40636398
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41008205
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40626224
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
41000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
41000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
524247000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
514362000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1068000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-397000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-362465000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302467000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
160755000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
211539000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195233000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
235000000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1882000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4381000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4474000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9170000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25019000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17378000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42850000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33712000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11098000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6685000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21857000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12183000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
36117000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
24063000
us-gaap Operating Expenses
OperatingExpenses
64707000
us-gaap Operating Expenses
OperatingExpenses
45895000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34235000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19682000
us-gaap Operating Income Loss
OperatingIncomeLoss
-60233000
us-gaap Operating Income Loss
OperatingIncomeLoss
-36725000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
165000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
34000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
235000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
78000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34070000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19648000
us-gaap Net Income Loss
NetIncomeLoss
-59998000
us-gaap Net Income Loss
NetIncomeLoss
-36647000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40890
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40890
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32636
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32636
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40768
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40768
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32076
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32076
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34070000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19648000
us-gaap Net Income Loss
NetIncomeLoss
-59998000
us-gaap Net Income Loss
NetIncomeLoss
-36647000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
22000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-671000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
22000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34048000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19653000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60669000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36654000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
95181000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
93000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2073000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16999000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
127754000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
242000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2546000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19648000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
110890000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
211539000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
395000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3847000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-693000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25928000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
189160000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
2764000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2879000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
22000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34070000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
160755000
us-gaap Profit Loss
ProfitLoss
-59998000
us-gaap Profit Loss
ProfitLoss
-36647000
us-gaap Depreciation
Depreciation
1212000
us-gaap Depreciation
Depreciation
1275000
us-gaap Share Based Compensation
ShareBasedCompensation
6726000
us-gaap Share Based Compensation
ShareBasedCompensation
4619000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-641000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-195000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2143000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-394000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
126000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-25000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1773000
fulc Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
42000
fulc Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
221000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1563000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-47000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
471000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
622000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3448000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
397000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2929000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7981000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49472000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34047000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15166000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
51785000
fulc Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
67784000
fulc Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
38673000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1564000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
827000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51054000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13939000
fulc Proceeds From Issuance Of Common Stock In Connection With Follow On Offering
ProceedsFromIssuanceOfCommonStockInConnectionWithFollowOnOffering
0
fulc Proceeds From Issuance Of Common Stock In Connection With Follow On Offering
ProceedsFromIssuanceOfCommonStockInConnectionWithFollowOnOffering
47407000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
18000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3159000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
324000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3159000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47713000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4741000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-273000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36504000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58144000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41245000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57871000
fulc Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
1400000
fulc Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
0
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
151000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
59000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40153000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56779000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1092000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1092000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41245000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57871000
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4600000
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
11.00
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
47400000
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7590000
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
19.00
CY2021Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
135500000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-362500000
CY2022Q2 fulc Cash Equivalents And Marketable Securities Amortized Cost Basis
CashEquivalentsAndMarketableSecuritiesAmortizedCostBasis
170041000
CY2022Q2 fulc Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax
CashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
-1068000
CY2022Q2 fulc Cash Equivalents And Marketable Securities Fair Value Disclosure
CashEquivalentsAndMarketableSecuritiesFairValueDisclosure
168973000
CY2021Q4 fulc Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
35412000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
35412000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
183147000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
397000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
182750000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amount of expenses during the reported periods. Estimates inherent in the preparation of these consolidated financial statements include, but are not limited to, estimates related to revenue recognition, accrued expenses, stock-based compensation expense, and income taxes. The Company bases its estimates on historical experience and other market specific or other relevant assumptions it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Actual results could differ from those estimates or assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q2 fulc Fair Value Transfers Between Levels1
FairValueTransfersBetweenLevels1
0
fulc Fair Value Transfers Between Levels1
FairValueTransfersBetweenLevels1
0
CY2022Q2 fulc Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
40153000
CY2022Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
40153000
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
129888000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1068000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
128820000
CY2021Q4 fulc Cash Equivalents And Marketable Securities Amortized Cost Basis
CashEquivalentsAndMarketableSecuritiesAmortizedCostBasis
218559000
CY2021Q4 fulc Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax
CashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
397000
CY2021Q4 fulc Cash Equivalents And Marketable Securities Fair Value Disclosure
CashEquivalentsAndMarketableSecuritiesFairValueDisclosure
218162000
CY2022Q2 fulc Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
0
fulc Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
0
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
128900000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2022Q2 fulc Aggregate Fair Value Of Securities Remaining Contractual Maturity Of Greater Than One Year
AggregateFairValueOfSecuritiesRemainingContractualMaturityOfGreaterThanOneYear
0
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17294000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15637000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9460000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8269000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7834000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7368000
CY2022Q2 us-gaap Depreciation
Depreciation
700000
CY2021Q2 us-gaap Depreciation
Depreciation
700000
us-gaap Depreciation
Depreciation
1200000
us-gaap Depreciation
Depreciation
1300000
CY2022Q2 fulc Prepaid Expenses
PrepaidExpenses
3562000
CY2021Q4 fulc Prepaid Expenses
PrepaidExpenses
3400000
CY2022Q2 fulc Prepaid Sign On Bonuses Subject To Vesting Provisions
PrepaidSignOnBonusesSubjectToVestingProvisions
220000
CY2021Q4 fulc Prepaid Sign On Bonuses Subject To Vesting Provisions
PrepaidSignOnBonusesSubjectToVestingProvisions
326000
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
392000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
473000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4174000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4199000
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
0
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
0
CY2022Q2 fulc Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
9038000
CY2021Q4 fulc Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
3171000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2733000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4990000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
688000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
996000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74000
CY2022Q2 fulc Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
12470000
CY2021Q4 fulc Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
9231000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders
CY2022Q2 fulc Number Of Common Stock Voting Rights
NumberOfCommonStockVotingRights
1
us-gaap Dividends
Dividends
0
us-gaap Share Based Compensation
ShareBasedCompensation
4619000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
40800000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M17D
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9974607
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6181336
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2879000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2546000
fulc Defined Contribution Plan Name
DefinedContributionPlanName
401(k)
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2021Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6252929
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4720160
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6252929
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4720160

Files In Submission

Name View Source Status
0000950170-22-016644-index-headers.html Edgar Link pending
0000950170-22-016644-index.html Edgar Link pending
0000950170-22-016644.txt Edgar Link pending
0000950170-22-016644-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fulc-20220630.htm Edgar Link pending
fulc-20220630.xsd Edgar Link pending
fulc-ex31_1.htm Edgar Link pending
fulc-ex31_2.htm Edgar Link pending
fulc-ex32_1.htm Edgar Link pending
fulc-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fulc-20220630_pre.xml Edgar Link unprocessable
fulc-20220630_lab.xml Edgar Link unprocessable
fulc-20220630_def.xml Edgar Link unprocessable
fulc-20220630_cal.xml Edgar Link unprocessable
fulc-20220630_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending